2-acetyl-thiophene thiosemicarbazone

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-acetyl-thiophene thiosemicarbazone
• 英文别名: [(Z)-1-thiophen-2-ylethylideneamino]thiourea
• 化学式: C₇H₉N₃S₂
• 分子量: 199.301
• InChiKey: PJVHAJJEMJNPHN-UITAMQMPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  111
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  catechol isopropylborate 、 2-acetyl-thiophene thiosemicarbazone 以 苯 为溶剂， 以65%的产率得到
  参考文献：
  名称：

  Saxena, Chitra; Singh, Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical and Analytical, 1996, vol. 35, # 8, p. 707 - 709

  摘要：

  DOI：
• 作为产物：
  描述：

  2-乙酰基噻吩 、 氨基硫脲 以 乙醇 为溶剂， 以70%的产率得到2-acetyl-thiophene thiosemicarbazone
  参考文献：
  名称：

  Chandra, Sulekh; Kumar, Anil, Journal of the Indian Chemical Society, 2006, vol. 83, # 10, p. 993 - 998

  摘要：

  DOI：

文献信息

• Peptidomimetics for the treatment of coronavirus and picornavirus infections
  申请人：Emory University

  公开号：US11207370B2

  公开（公告）日：2021-12-28

  Compounds, compositions and methods for preventing, treating or curing a coronavirus, picornavirus, and/or hepeviridae virus infection in human subjects or other animal hosts. Specific viruses that can be treated include enteroviruses. In one embodiment, the compounds can be used to treat an infection with a severe acute respiratory syndrome virus, such as human coronavirus 229E, SARS, MERS, SARS-CoV-1 (OC43), and SARS-CoV-2. In another embodiment, the methods are used to treat a patient co-infected with two or more of these viruses, or a combination of one or more of these viruses and norovirus.

  用于预防、治疗或治愈人类或其他动物宿主冠状病毒、皮卡病毒和/或肝病毒科病毒感染的化合物、组合物和方法。可治疗的特定病毒包括肠道病毒。在一个实施方案中，化合物可用于治疗严重急性呼吸系统综合征病毒感染，如人冠状病毒 229E、SARS、MERS、SARS-CoV-1（OC43）和 SARS-CoV-2。在另一个实施方案中，这些方法用于治疗合并感染两种或两种以上这些病毒的患者，或合并感染一种或多种这些病毒和诺如病毒的患者。
• Fahmi, Nighat; Singh, Journal of the Indian Chemical Society, 1996, vol. 73, # 6, p. 257 - 259
  作者：Fahmi, Nighat、Singh

  DOI：——

  日期：——
• Chandra, Sulekh; Kumar, Anil, Journal of the Indian Chemical Society, 2006, vol. 83, # 10, p. 993 - 998
  作者：Chandra, Sulekh、Kumar, Anil

  DOI：——

  日期：——
• PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS
  申请人：Emory University

  公开号：US20210008150A1

  公开（公告）日：2021-01-14

  Compounds, compositions and methods for preventing, treating or curing a coronavirus, picornavirus, and/or hepeviridae virus infection in human subjects or other animal hosts. Specific viruses that can be treated include enteroviruses. In one embodiment, the compounds can be used to treat an infection with a severe acute respiratory syndrome virus, such as human coronavirus 229E, SARS, MERS, SARS-CoV-1 (OC43), and SARS-CoV-2. In another embodiment, the methods are used to treat a patient co-infected with two or more of these viruses, or a combination of one or more of these viruses and norovirus.
• NITRIC OXIDE-RELEASING ANTIBACTERIAL COMPOUNDS, FORMULATIONS, AND METHODS PERTAINING THERETO
  申请人：KNOW BIO, LLC

  公开号：US20220152063A1

  公开（公告）日：2022-05-19

  Several embodiments of NO releasing compounds are disclosed. In some embodiments, the structures are covalently modified to store and release nitric oxide. Some embodiments pertain to methods of making and use of these structures. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for treating or preventing microbial infections, or reducing the microbial load of a microbial infection.